Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612724 · ClinicalTrials.gov registry record · NA
Rutgers Pilot for PREDICT- Patient POC Test
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05612724 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 14 participants.
The verdict
NCT05612724, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral antigen using a point-of-care (POC) Rapid Antigen test. 14 subjects with upcoming appointment at the Oral Medicine clinic, Rutgers School of Dental Medicine, with no history of documented COVID-19 infection or viral exposure, were enrolled in a study that interrogated patients' perceptions of safety and feedback regarding their testing experience. All 14 patients expressed initial interest, however, 10 patients completed informed consent and completed study procedures. Institutional Clinical Laboratory Improvement Amendments (CLIA) certification of waiver was obtained prior to conducting the study. Communicable Diseases Reporting and Surveillance System (CDRSS) registration and training were completed to enable reporting results of the POC test.
Interventions
- DEVICE Testing for SARS CoV2 Antigen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612724
The ClinicalTrials.gov registry entry for NCT05612724 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testing for SARS CoV2 Antigen is the first listed.
NCT05612724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05612724 about?
NCT05612724 is a clinical study titled "Rutgers Pilot for PREDICT- Patient POC Test". A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral antigen using a point-of-care (POC) Rapid Antigen test. 14 subjects with upcoming appointment at the Oral Medici...
What is the current status of trial NCT05612724?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-12-30. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05612724?
The interventions under investigation include: Testing for SARS CoV2 Antigen (DEVICE).
Who is sponsoring clinical trial NCT05612724?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.